Current role
Biotechnology · Healthcare
Board Member
2025-12-16–present
Adrian Bot, M.D., Ph.D.
Board Member
Cartesian Therapeutics, Inc. (RNAC)Equibles does not estimate personal net worth.
Get an email with a short summary when Cartesian Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RNAC alertsAbout Adrian Bot, M.D., Ph.D.
Adrian Bot, M.D., Ph.D. is recorded as Board Member at Cartesian Therapeutics, Inc. (RNAC) since December 16, 2025. Cartesian Therapeutics, Inc. reported in an 8-K filed December 18, 2025 that Adrian Bot, M.D., Ph.D. was appointed Class II director, effective December 16, 2025. Cartesian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cartesian Therapeutics, Inc. includes Carsten Brunn (CEO and Board Member), Carsten Brunn, Ph.D. (Chairman), Blaine Davis (CFO and Chief Accounting Officer) and 7 others.
“On December 16, 2025, the Board of Directors (the "Board") of Cartesian Therapeutics, Inc. (the "Company") appointed Adrian Bot, M.D., Ph.D. as a Class II director.”
Affiliation history
-
Current
2025-12-16–present
Company network
Leadership on record at Cartesian Therapeutics, Inc.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Kevin Tan CFO
- Metin Kurtoglu COO
- Metin Kurtoglu, M.D., Ph.D. COO
- June Seymour Chief Accounting Officer
- Adrian Bot Board Member
- Carrie S. Cox Board Member
- Kemal Malik Board Member